Analysts Set Phibro Animal Health Co. (NASDAQ:PAHC) Price Target at $15.00

Phibro Animal Health Co. (NASDAQ:PAHC) has received a consensus recommendation of “Strong Sell” from the five ratings firms that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell rating and two have assigned a hold rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $15.00.

PAHC has been the topic of a number of recent analyst reports. Bank of America boosted their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $22.18 on Friday. The company has a market capitalization of $898.36 million, a price-to-earnings ratio of 69.31, a PEG ratio of 1.75 and a beta of 0.52. The company has a quick ratio of 1.64, a current ratio of 2.94 and a debt-to-equity ratio of 1.79. Phibro Animal Health has a twelve month low of $9.40 and a twelve month high of $22.84. The stock has a fifty day simple moving average of $20.16 and a 200 day simple moving average of $17.72.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The company had revenue of $273.16 million during the quarter, compared to analysts’ expectations of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Sell-side analysts expect that Phibro Animal Health will post 1.44 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.16%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio is presently 150.00%.

Insider Buying and Selling at Phibro Animal Health

In related news, Director E Thomas Corcoran acquired 5,000 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were bought at an average price of $20.02 per share, with a total value of $100,100.00. Following the transaction, the director now directly owns 25,000 shares of the company’s stock, valued at $500,500. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 50.06% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors have recently modified their holdings of PAHC. Sofinnova Investments Inc. acquired a new position in Phibro Animal Health during the second quarter worth $3,975,000. American Century Companies Inc. raised its holdings in shares of Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after acquiring an additional 189,068 shares during the last quarter. Acadian Asset Management LLC lifted its position in Phibro Animal Health by 32.8% in the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock valued at $8,726,000 after acquiring an additional 166,776 shares in the last quarter. Wellington Management Group LLP boosted its stake in Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after purchasing an additional 102,793 shares during the last quarter. Finally, Dana Investment Advisors Inc. increased its holdings in Phibro Animal Health by 17.2% during the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after purchasing an additional 75,546 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.